OM
Outset Medical, Inc.
Price Chart
Latest Quote
$4.88
-0.17 (-3.37%)
Current Price
| Previous Close | $5.05 |
| Open | $5.04 |
| Day High | $5.24 |
| Day Low | $4.83 |
| Volume | 209,443 |
Stock Information
| Shares Outstanding | 18.54M |
| Total Debt | $101.61M |
| Cash Equivalents | $156.71M |
| Revenue | $117.59M |
| Net Income | $-74.85M |
| Sector | Healthcare |
| Industry | Medical Devices |
| Market Cap | $90.46M |
| EPS (TTM) | $-2.74 |
| Exchange | NMS |
đ Comprehensive Analysis
Company Data
| Enterprise Value | $35.37M |
| Sales | $117.59M |
| Income | $-74.85M |
| Book/sh | $6.03 |
| Cash/sh | $8.45 |
| Employees | 310 |
Financial Ratios
| Quick Ratio | 4.84 |
| Current Ratio | 6.29 |
| Debt/Eq | 90.98 |
Returns & Margins
| ROA | -15.26% |
| ROE | -53.17% |
| Gross Margin | 40.64% |
| Operating Margin | -60.72% |
| Profit Margin | -63.65% |
Ownership
| Insider Ownership | 3.83% |
| Institutional Ownership | 84.18% |
| Insider & Institutional transactions data not available | |
Valuation Ratios
| Forward P/E | -2.24 |
| P/S | 0.77 |
| P/B | 0.81 |
Analyst Data
| Recommendation | buy |
| Target Price | $7.67 |
Technical Indicators
| SMA20 | $4.60 |
| SMA50 | $4.39 |
| SMA200 | $6.56 |
| RSI | 49.62 |
| ATR | 0.4599 |
| Shares Float | 15.43M |
| Short Float | 16.30% |
| Short Ratio | 11.72 |
| Volatility | 1.94 |
| Rel Volume | 1.03 |
Performance History
| Week | +8.69% |
| Month | +11.42% |
| Quarter | +45.24% |
| 6 Months | +29.44% |
| YTD | +31.89% |
| Year | -75.06% |
| 3 Years | -98.58% |
| 5 Years | -99.33% |
| 10 Years | -99.46% |
Stock Score:
â Premium
Based on debt, profitability, growth, and cash flow metrics
â Premium Feature
Sign up for free to view detailed scoring breakdown â premium is free during our trial period!
Recent Price History
| Date | Close | Volume |
|---|---|---|
| 2026-06-22 | $4.88 | 211,900 |
| 2026-06-18 | $5.05 | 525,700 |
| 2026-06-17 | $4.02 | 91,000 |
| 2026-06-16 | $4.41 | 255,400 |
| 2026-06-15 | $4.31 | 258,700 |
| 2026-06-12 | $4.49 | 146,700 |
| 2026-06-11 | $4.30 | 140,900 |
| 2026-06-10 | $4.62 | 180,100 |
| 2026-06-09 | $4.69 | 192,900 |
| 2026-06-08 | $4.32 | 84,000 |
| 2026-06-05 | $4.58 | 128,600 |
| 2026-06-04 | $4.73 | 178,000 |
| 2026-06-03 | $4.60 | 328,600 |
| 2026-06-02 | $5.07 | 209,700 |
| 2026-06-01 | $4.91 | 233,800 |
| 2026-05-29 | $4.89 | 180,500 |
| 2026-05-28 | $5.01 | 385,000 |
| 2026-05-27 | $4.39 | 117,400 |
| 2026-05-26 | $4.40 | 152,100 |
About Outset Medical, Inc.
Outset Medical, Inc., a medical technology company, engages in the development of a hemodialysis system for hemodialysis in the United States. The company provides Tablo Hemodialysis System, a compact console with integrated water purification, on-demand dialysate production, and software and connectivity capabilities; and manufactures, supports, and distributes for Tablo console, Tablo cartridge, and other consumables. It also offers Tablo Data Ecosystem, including TabloHub, a consumer-facing portal; MyTablo, a patient-facing portal; and TabloDash, an internal data analytics platform. The company was formerly known as Home Dialysis Plus, Ltd. and changed its name to Outset Medical, Inc. in January 2015. Outset Medical, Inc. was incorporated in 2003 and is headquartered in San Jose, California.
đ° Latest News
Outset Medical (OM) Surges 25.6%: Is This an Indication of Further Gains?
Zacks âĸ 2026-06-19T08:25:00Z
Hereâs Why Outset Medical (OM) Rebound Sharply After Last Quarterâs Selloff
Insider Monkey âĸ 2026-05-13T09:09:47Z
Outset Medical (OM) Q4 2025 Earnings Transcript
Motley Fool âĸ 2026-05-09T18:08:09Z
Outset Medical Q1 Earnings Call Highlights
MarketBeat âĸ 2026-05-08T12:07:14Z
Outset Medical, Inc. (OM) Reports Q1 Loss, Lags Revenue Estimates
Zacks âĸ 2026-05-07T21:55:07Z
Outset Medical (OM) Q1 2026 Earnings Transcript
Motley Fool âĸ 2026-05-07T21:51:07Z
Analyst Sentiment on Outset Medical (OM) Remains Strong Following Q4 Results
Insider Monkey âĸ 2026-02-20T21:39:17Z
US$10.50: That's What Analysts Think Outset Medical, Inc. (NASDAQ:OM) Is Worth After Its Latest Results
Simply Wall St. âĸ 2026-02-14T12:16:50Z
Outset Medical, Inc. Q4 2025 Earnings Call Summary
Moby âĸ 2026-02-12T13:30:00Z
Outset Medical Inc (OM) Q4 2025 Earnings Call Highlights: Strategic Advances and Financial ...
GuruFocus.com âĸ 2026-02-12T05:02:13Z
Period:
Loading...
Income Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Revenue | ||||
| Reconciled Cost Of Revenue | $72,722,000 | $75,125,000 | $101,376,000 | $97,542,000 |
| Cost Of Revenue | $72,722,000 | $75,125,000 | $101,376,000 | $97,542,000 |
| Total Revenue | $119,476,000 | $113,689,000 | $130,376,000 | $115,375,000 |
| Operating Revenue | $119,476,000 | $113,689,000 | $130,376,000 | $115,375,000 |
| Expenses | ||||
| Interest Expense | $13,952,000 | $23,871,000 | $12,675,000 | $3,566,000 |
| Total Expenses | $186,182,000 | $227,064,000 | $300,146,000 | $276,394,000 |
| Other Income Expense | $-7,685,000 | - | - | $-1,367,000 |
| Net Non Operating Interest Income Expense | $-6,544,000 | $-14,110,000 | $-2,504,000 | $-275,000 |
| Interest Expense Non Operating | $13,952,000 | $23,871,000 | $12,675,000 | $3,566,000 |
| Operating Expense | $113,460,000 | $151,939,000 | $198,770,000 | $178,852,000 |
| Selling And Marketing Expense | $54,361,000 | $70,044,000 | $96,232,000 | $89,482,000 |
| General And Administrative Expense | $37,864,000 | $43,498,000 | $45,231,000 | $40,515,000 |
| Income & Earnings | ||||
| Net Income From Continuing Operation Net Minority Interest | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Net Interest Income | $-6,544,000 | $-14,110,000 | $-2,504,000 | $-275,000 |
| Interest Income | $7,408,000 | $9,761,000 | $10,171,000 | $3,291,000 |
| Normalized Income | $-75,581,850 | $-127,976,000 | $-172,797,000 | $-161,876,070 |
| Net Income From Continuing And Discontinued Operation | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Total Operating Income As Reported | $-66,706,000 | $-113,375,000 | $-169,770,000 | $-161,019,000 |
| Net Income Common Stockholders | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Net Income | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Net Income Including Noncontrolling Interests | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Net Income Continuous Operations | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Pretax Income | $-80,935,000 | $-127,485,000 | $-172,274,000 | $-162,661,000 |
| Special Income Charges | $-7,685,000 | $0 | $0 | $-1,367,000 |
| Interest Income Non Operating | $7,408,000 | $9,761,000 | $10,171,000 | $3,291,000 |
| Operating Income | $-66,706,000 | $-113,375,000 | $-169,770,000 | $-161,019,000 |
| Gross Profit | $46,754,000 | $38,564,000 | $29,000,000 | $17,833,000 |
| Per Share | ||||
| Diluted EPS | $-5.37 | $-36.90 | $-52.20 | $-50.70 |
| Basic EPS | $-5.37 | $-36.90 | $-52.20 | $-50.70 |
| Other | ||||
| Tax Effect Of Unusual Items | $-1,613,850 | $0 | $0 | $-287,070 |
| Tax Rate For Calcs | $0 | $0 | $0 | $0 |
| Normalized EBITDA (Bullshit earnings) | $-54,957,000 | $-97,886,000 | $-153,789,000 | $-152,559,000 |
| Total Unusual Items | $-7,685,000 | $0 | $0 | $-1,367,000 |
| Total Unusual Items Excluding Goodwill | $-7,685,000 | $0 | $0 | $-1,367,000 |
| Reconciled Depreciation | $4,341,000 | $5,728,000 | $5,810,000 | $5,169,000 |
| EBITDA (Bullshit earnings) | $-62,642,000 | $-97,886,000 | $-153,789,000 | $-153,926,000 |
| EBIT | $-66,983,000 | $-103,614,000 | $-159,599,000 | $-159,095,000 |
| Diluted Average Shares | $15,211,000 | $3,463,400 | $3,305,866 | $3,210,733 |
| Basic Average Shares | $15,211,000 | $3,463,400 | $3,305,866 | $3,210,733 |
| Diluted NI Availto Com Stockholders | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Tax Provision | $718,000 | $491,000 | $523,000 | $295,000 |
| Other Special Charges | $7,685,000 | - | - | $1,367,000 |
| Research And Development | $21,235,000 | $38,397,000 | $57,307,000 | $48,855,000 |
| Selling General And Administration | $92,225,000 | $113,542,000 | $141,463,000 | $129,997,000 |
| Other Gand A | $37,864,000 | $43,498,000 | $45,231,000 | $40,515,000 |
| Otherunder Preferred Stock Dividend | - | - | - | $0 |
Fetched: 2026-06-21
Balance Sheet (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Assets | ||||
| Net Tangible Assets | $126,952,000 | $26,819,000 | $122,886,000 | $245,990,000 |
| Total Assets | $264,496,000 | $275,795,000 | $313,801,000 | $400,115,000 |
| Total Non Current Assets | $13,613,000 | $17,574,000 | $22,582,000 | $26,470,000 |
| Other Non Current Assets | $4,146,000 | $5,501,000 | $3,934,000 | $4,477,000 |
| Current Assets | $250,883,000 | $258,221,000 | $291,219,000 | $373,645,000 |
| Other Current Assets | $5,999,000 | $4,530,000 | $5,700,000 | $6,597,000 |
| Inventory | $47,609,000 | $59,387,000 | $49,215,000 | $51,476,000 |
| Receivables | $28,329,000 | $35,619,000 | $32,980,000 | $28,070,000 |
| Accounts Receivable | $28,329,000 | $35,619,000 | $32,980,000 | $28,070,000 |
| Cash Cash Equivalents And Short Term Investments | $168,946,000 | $158,685,000 | $203,324,000 | $287,502,000 |
| Cash And Cash Equivalents | $35,006,000 | $124,014,000 | $68,509,000 | $73,222,000 |
| Prepaid Assets | - | - | - | - |
| Debt | ||||
| Net Debt | $61,231,000 | $73,361,000 | $61,604,000 | $23,114,000 |
| Total Debt | $101,247,000 | $201,858,000 | $136,188,000 | $103,230,000 |
| Long Term Debt And Capital Lease Obligation | $99,508,000 | $200,059,000 | $134,595,000 | $101,912,000 |
| Long Term Debt | $96,237,000 | $197,375,000 | $130,113,000 | $96,336,000 |
| Current Debt And Capital Lease Obligation | $1,739,000 | $1,799,000 | $1,593,000 | $1,318,000 |
| Liabilities | ||||
| Total Liabilities Net Minority Interest | $137,544,000 | $248,976,000 | $190,915,000 | $154,125,000 |
| Total Non Current Liabilities Net Minority Interest | $99,914,000 | $203,598,000 | $135,592,000 | $102,176,000 |
| Non Current Deferred Liabilities | $406,000 | $844,000 | $101,000 | $151,000 |
| Current Liabilities | $37,630,000 | $45,378,000 | $55,323,000 | $51,949,000 |
| Other Current Liabilities | $4,070,000 | $3,090,000 | $5,761,000 | $7,109,000 |
| Current Deferred Liabilities | $13,795,000 | $12,753,000 | $11,727,000 | $8,662,000 |
| Payables And Accrued Expenses | $7,291,000 | $10,915,000 | $17,237,000 | $13,341,000 |
| Payables | $554,000 | $3,862,000 | $5,827,000 | $603,000 |
| Accounts Payable | $554,000 | $3,862,000 | $5,827,000 | $603,000 |
| Equity | ||||
| Common Stock Equity | $126,952,000 | $26,819,000 | $122,886,000 | $245,990,000 |
| Total Equity Gross Minority Interest | $126,952,000 | $26,819,000 | $122,886,000 | $245,990,000 |
| Stockholders Equity | $126,952,000 | $26,819,000 | $122,886,000 | $245,990,000 |
| Gains Losses Not Affecting Retained Earnings | $172,000 | $42,000 | $68,000 | $-564,000 |
| Other Equity Adjustments | $172,000 | $42,000 | $68,000 | $-564,000 |
| Retained Earnings | $-1,171,376,000 | $-1,089,723,000 | $-961,747,000 | $-788,950,000 |
| Other | ||||
| Ordinary Shares Number | $18,169,000 | $3,529,600 | $3,354,466 | $3,231,000 |
| Share Issued | $18,169,000 | $3,529,600 | $3,354,466 | $3,231,000 |
| Tangible Book Value | $126,952,000 | $26,819,000 | $122,886,000 | $245,990,000 |
| Invested Capital | $223,189,000 | $224,194,000 | $252,999,000 | $342,326,000 |
| Working Capital | $213,253,000 | $212,843,000 | $235,896,000 | $321,696,000 |
| Capital Lease Obligations | $5,010,000 | $4,483,000 | $6,075,000 | $6,894,000 |
| Total Capitalization | $223,189,000 | $224,194,000 | $252,999,000 | $342,326,000 |
| Additional Paid In Capital | $1,298,138,000 | $1,116,496,000 | $1,084,515,000 | $1,035,456,000 |
| Capital Stock | $18,000 | $4,000 | $50,000 | $48,000 |
| Common Stock | $18,000 | $4,000 | $50,000 | $48,000 |
| Preferred Stock | $0 | $0 | $0 | $0 |
| Non Current Accrued Expenses | $0 | $2,695,000 | $896,000 | $113,000 |
| Non Current Deferred Revenue | $406,000 | $844,000 | $101,000 | $151,000 |
| Long Term Capital Lease Obligation | $3,271,000 | $2,684,000 | $4,482,000 | $5,576,000 |
| Current Deferred Revenue | $13,795,000 | $12,753,000 | $11,727,000 | $8,662,000 |
| Current Capital Lease Obligation | $1,739,000 | $1,799,000 | $1,593,000 | $1,318,000 |
| Pensionand Other Post Retirement Benefit Plans Current | $10,735,000 | $16,821,000 | $19,005,000 | $21,519,000 |
| Current Accrued Expenses | $6,737,000 | $7,053,000 | $11,410,000 | $12,738,000 |
| Net PPE | $9,467,000 | $12,073,000 | $18,648,000 | $21,993,000 |
| Accumulated Depreciation | $-24,899,000 | $-21,025,000 | $-16,372,000 | $-10,807,000 |
| Gross PPE | $34,366,000 | $33,098,000 | $35,020,000 | $32,800,000 |
| Leases | $9,580,000 | $9,685,000 | $9,621,000 | $5,040,000 |
| Construction In Progress | $523,000 | $637,000 | $769,000 | $4,773,000 |
| Other Properties | $4,797,000 | $4,178,000 | $5,897,000 | $6,831,000 |
| Machinery Furniture Equipment | $19,466,000 | $18,598,000 | $18,733,000 | $16,156,000 |
| Properties | $0 | $0 | $0 | $0 |
| Finished Goods | $13,110,000 | $23,711,000 | $21,781,000 | $21,767,000 |
| Work In Process | $7,316,000 | $9,973,000 | $8,728,000 | $9,086,000 |
| Raw Materials | $27,183,000 | $25,703,000 | $18,706,000 | $20,623,000 |
| Other Short Term Investments | $133,940,000 | $34,671,000 | $134,815,000 | $214,280,000 |
| Treasury Shares Number | - | - | $0 | - |
| Current Provisions | - | - | - | - |
Fetched: 2026-06-21
Cash Flow Statement (Annual)
| Metric | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 |
|---|---|---|---|---|
| Free Cash Flow | ||||
| Free Cash Flow | $-47,125,000 | $-117,215,000 | $-134,813,000 | $-154,054,000 |
| Operating Activities | ||||
| Operating Cash Flow | $-46,327,000 | $-116,303,000 | $-131,373,000 | $-145,729,000 |
| Cash Flow From Continuing Operating Activities | $-46,327,000 | $-116,303,000 | $-131,373,000 | $-145,729,000 |
| Operating Gains Losses | $7,690,000 | $53,000 | $106,000 | $1,406,000 |
| Investing Activities | ||||
| Capital Expenditure | $-798,000 | $-912,000 | $-3,440,000 | $-8,325,000 |
| Investing Cash Flow | $-97,684,000 | $103,938,000 | $83,026,000 | $-66,295,000 |
| Cash Flow From Continuing Investing Activities | $-97,684,000 | $103,938,000 | $83,026,000 | $-66,295,000 |
| Financing Activities | ||||
| Issuance Of Capital Stock | $161,548,000 | $0 | $0 | $0 |
| Financing Cash Flow | $55,503,000 | $67,870,000 | $43,652,000 | $72,898,000 |
| Cash Flow From Continuing Financing Activities | $55,503,000 | $67,870,000 | $43,652,000 | $72,898,000 |
| Net Preferred Stock Issuance | $161,548,000 | $0 | $0 | $0 |
| Preferred Stock Issuance | $161,548,000 | $0 | $0 | $0 |
| Net Other Financing Charges | - | $-938,000 | - | - |
| Net Common Stock Issuance | - | - | $0 | $0 |
| Common Stock Issuance | - | - | $0 | $0 |
| Other | ||||
| Repayment Of Debt | $-204,954,000 | $0 | $0 | $-31,203,000 |
| Issuance Of Debt | $98,270,000 | $66,524,000 | $33,225,000 | $96,059,000 |
| Interest Paid Supplemental Data | $15,634,000 | $20,685,000 | $10,847,000 | $3,185,000 |
| Income Tax Paid Supplemental Data | $447,000 | $593,000 | $491,000 | $385,000 |
| End Cash Position | $38,835,000 | $127,343,000 | $71,838,000 | $76,533,000 |
| Beginning Cash Position | $127,343,000 | $71,838,000 | $76,533,000 | $215,659,000 |
| Changes In Cash | $-88,508,000 | $55,505,000 | $-4,695,000 | $-139,126,000 |
| Proceeds From Stock Option Exercised | $639,000 | $2,284,000 | $10,427,000 | $8,042,000 |
| Net Issuance Payments Of Debt | $-106,684,000 | $66,524,000 | $33,225,000 | $64,856,000 |
| Net Long Term Debt Issuance | $-106,684,000 | $66,524,000 | $33,225,000 | $64,856,000 |
| Long Term Debt Payments | $-204,954,000 | $0 | $0 | $-31,203,000 |
| Long Term Debt Issuance | $98,270,000 | $66,524,000 | $33,225,000 | $96,059,000 |
| Net Investment Purchase And Sale | $-96,886,000 | $104,850,000 | $86,466,000 | $-57,970,000 |
| Sale Of Investment | $125,083,000 | $261,434,000 | $258,750,000 | $203,184,000 |
| Purchase Of Investment | $-221,969,000 | $-156,584,000 | $-172,284,000 | $-261,154,000 |
| Net PPE Purchase And Sale | $-798,000 | $-912,000 | $-3,440,000 | $-8,325,000 |
| Purchase Of PPE | $-798,000 | $-912,000 | $-3,440,000 | $-8,325,000 |
| Change In Working Capital | $2,200,000 | $-25,688,000 | $-773,000 | $-21,142,000 |
| Change In Other Working Capital | $604,000 | $1,769,000 | $3,015,000 | $2,161,000 |
| Change In Other Current Liabilities | $-1,913,000 | $-1,593,000 | $-1,347,000 | $-1,150,000 |
| Change In Payables And Accrued Expense | $-11,119,000 | $-10,779,000 | $267,000 | $-3,702,000 |
| Change In Accrued Expense | $-7,826,000 | $-8,831,000 | $-5,045,000 | $-2,421,000 |
| Change In Interest Payable | $-2,695,000 | $0 | $0 | $-721,000 |
| Change In Payable | $-3,293,000 | $-1,948,000 | $5,312,000 | $-1,281,000 |
| Change In Account Payable | $-3,293,000 | $-1,948,000 | $5,312,000 | $-1,281,000 |
| Change In Prepaid Assets | $-940,000 | $784,000 | $739,000 | $-1,215,000 |
| Change In Inventory | $11,793,000 | $-10,857,000 | $1,647,000 | $-14,730,000 |
| Change In Receivables | $3,775,000 | $-5,012,000 | $-5,094,000 | $-2,506,000 |
| Changes In Account Receivables | $3,775,000 | $-5,012,000 | $-5,094,000 | $-2,506,000 |
| Other Non Cash Items | $4,341,000 | $4,009,000 | $3,099,000 | $1,495,000 |
| Stock Based Compensation | $15,616,000 | $29,356,000 | $38,634,000 | $27,203,000 |
| Provisionand Write Offof Assets | $3,391,000 | $2,935,000 | $917,000 | $2,647,000 |
| Amortization Of Securities | $-2,253,000 | $-4,720,000 | $-6,369,000 | $449,000 |
| Depreciation Amortization Depletion | $4,341,000 | $5,728,000 | $5,810,000 | $5,169,000 |
| Depreciation And Amortization | $4,341,000 | $5,728,000 | $5,810,000 | $5,169,000 |
| Gain Loss On Sale Of PPE | $5,000 | $53,000 | $106,000 | $39,000 |
| Net Income From Continuing Operations | $-81,653,000 | $-127,976,000 | $-172,797,000 | $-162,956,000 |
| Depreciation | - | - | - | - |
Fetched: 2026-06-21